BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$340.45 USD
+6.79 (2.04%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $340.42 -0.03 (-0.01%) 6:28 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BIO 340.45 +6.79(2.04%)
Will BIO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BIO
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
National Vision (EYE) Down 6.9% Since Last Earnings Report: Can It Rebound?
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now
Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure
Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered
Other News for BIO
UBS highlights 30 stocks poised for potential moves after the Fed’s expected rate cut
Bio-Rad COO Last sells $990K in company shares
Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23
S&P announces changes to S&P 400, 600 indexes for quarterly rebalance